Status:
UNKNOWN
Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly
Lead Sponsor:
Pharmbio Korea Co., Ltd.
Conditions:
Colonic Disease
Intestinal Disease
Eligibility:
All Genders
70+ years
Phase:
PHASE4
Brief Summary
This study compares the effectiveness and stability of intestinal tablet (OST), an oral sulfate table (OST), developed in the form of pills, with 2L-PEG/Asc for examinees aged 70 or older who are sche...
Detailed Description
This study is comparison for efficacy and safety of bowel preparation between oral sulfate table and 2L-polyethylene glycol/ascorbate in elderly: multicenter, prospective, investigator single-blinded,...
Eligibility Criteria
Inclusion
- age over 70
- Patients who is scheduled a colonoscopy
- Patients who is informed and give a consent in voluntary
Exclusion
- History of colectomy
- Patients over American Society of Anesthesiology class III
- Patients who has difficulty swallowing
- In the case of abnormal findings requiring treatment in the basic blood test
- Patients with uncontrollable chronic diseases
- Patients suspected of having Paralytic ileus or intestinal obstruction.
- Patients who complains of alarm sign (severe abdominal pain, weight loss, anemia, gastrointestinal bleeding, etc.)
- Patients who has a history of drug abuse and addiction
- Patients who for any reason, are deemed by the Investigator to be inappropriate for this study
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT05249335
Start Date
February 1 2022
End Date
February 1 2024
Last Update
February 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.